Neurologyca
PrivateLast Round
VC Round
Apr 24, 2024
Company Overview
Neurologyca is an artificial intelligence company that provides a human context platform layer designed to help intelligent systems understand and adapt to human signals and intent in real time.
Sector
AI, Data & Cloud Infrastructure
Verticals
NLP & Conversational AI, Computer Vision, HR, Customer Experience
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurologyca Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neurologyca Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 24, 2024 |
Neurologyca Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sama Capital | VC Round |
| SEGO Venture | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2024
$3.1M round led by SEGO Venture.
Neurologyca Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurologyca's valuation, stock price, and market status.